An Eastern cooperative oncology group evaluation of combinations of methyl-CCNU, mitomycin C, adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277)

Journal of Clinical Oncology

Volumn 2, Issue 12, 1984, Pages 1372-1381

  Douglass Jr , H O ^a   Lavin, P T ^a   Goudsmit, A ^a   Klaassen, D J ^b   Paul, A R ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FLUOROURACIL; MITOMYCIN; MITOMYCIN C; SEMUSTINE;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; DRUG COMPARISON; DRUG EFFICACY; DRUG THERAPY; GASTROINTESTINAL TOXICITY; HEART; HEART FAILURE; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STOMACH; STOMACH CARCINOMA; THERAPY; VOMITING;

EID: 0021702132     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1984.2.12.1372     Document Type: Article

References (0)